Year: 2014
Type: article
Study design: Observational Study
Abstract: Outbreaks of Ebola virus disease (EVD) occur sporadically in Africa and are associated with high case-fatality rates.Historically, children have been less affected than adults.The 2000The -2001 Sudan virus-associated EVD outbreak in the Gulu district of Uganda resulted in 55 pediatric and 161 adult laboratory-confirmed cases.We used a series of multiplex assays to measure the concentrations of 55 serum analytes in specimens from patients from that outbreak to identify biomarkers specific to pediatric disease.Pediatric patients who survived had higher levels of the chemokine regulated on activation, normal T-cell expressed and secreted marker and lower levels of plasminogen activator inhibitor 1, soluble intracellular adhesion molecule, and soluble vascular cell adhesion molecule than did pediatric patients who died.Adult patients had similar levels of these analytes regardless of outcome.Our findings suggest that children with EVD may benefit from different treatment regimens than those for adults.O utbreaks of Ebola virus disease (EVD) occur spo- radically in sub-Saharan Africa and are associated with exceptionally high case-fatality rates (CFRs).The disease onset is nonspecific and is characterized by abrupt onset of fever, fatigue, headache, myalgia, and gastrointestinal distress 3-13 days after exposure to the virus (1).The term hemorrhagic fever has been used to describe this disease process because hemorrhagic manifestations develop in many patients during the course of illness.The Ebolavirus genus includes 5 different viruses that result in different CFRs: Ebola virus (EBOV; CFR 57%-90%), Sudan virus (SUDV; CFR 41%-65%), and Bundibugyo virus (CFR 40%) cause fatal infections, but neither Tai Forest virus nor Reston virus has been associated with human fatalities (2,3).Pediatric patients have been underrepresented in EVD studies because total numbers of affected children in any given EVD outbreak, whether associated with EBOV, SUDV, or Bundibugyo virus, are usually low because of outbreak dynamics and societal structure.For example, nosocomial EVD infections mostly occur in adults working on hospital wards, and children are not usually caregivers for EVD patients.However, the 2000-2001 SUDV outbreak in the Gulu district of Uganda, the largest recorded EVD outbreak to that point, resulted in 425 cases; 145 cases were in patients <21 years of age, and 55 of these cases were laboratory confirmed (4,5).The CFR for pediatric patients in this outbreak was lower than for adults (6), but the reasons for this increased survival were unknown.The relatively large number of pediatric cases in this outbreak enabled closer investigation of factors associated with increased survival of pediatric patients with EVD.Samples collected during the Gulu outbreak have been invaluable for advancing understanding of EVD pathophysiology.Studies using these samples found associations between fatal outcomes and elevated liver enzyme levels, renal dysfunction, cytokine dysregulation, and genetic factors (7-9).Recently, we analyzed serum biomarkers by using samples from the Gulu outbreak and identified associations between cytokines/chemokines, acute-phase reactants, makers of coagulopathy, and markers of endothelial function and patient death, hemorrhage, and viremia (10).In this study, we used a series of multiplex assays to measure the concentrations of 55 serum analytes in specimens from patients from the Gulu outbreak to identify biomarkers that had age-specific associations with survival, hemorrhagic manifestations, or both. Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
Source: Emerging infectious diseases
Institutions: Centers for Disease Control and Prevention, Emory University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W1983706146
